Patrick Machado
Outside Director
Pharmaceutical
Inotek Pharamaceuticals
United States of America
Biography
Mr. Machado is a co-founder of Medivation, Inc., a publicly held biopharmaceutical company, and served as its Chief Business Officer from December 2009 to April 2014 and as its Chief Financial Officer from December 2004 until March 2014. From 1998 to 2001, Mr. Machado was employed by ProDuct Health, Inc., a privately held medical device company, as Vice President, Chief Financial Officer and General Counsel from 1998 to 2000 and as Senior Vice President and Chief Financial Officer from 2000 to 2001. From 2001 to 2002, Mr. Machado served as a consultant to Cytyc Corporation to assist with transitional matters related to Cytyc Corporation’s acquisition of ProDuct Health, Inc. Mr. Machado currently serves on the board of directors of Medivation, Inc. (NASDAQ: MDVN), Chimerix, Inc. (NASDAQ: CMRX), a biopharmaceutical company, and Scynexis, Inc. (NASDAQ: SCYX), a biopharmaceutical company, and serves as the chair of the board of directors of Armaron Bio Pty. Ltd., a privately held biopharmaceutical company based in Melbourne, Australia. Mr. Machado received a JD from Harvard Law School and a BA and BS in German and Economics, respectively, from Santa Clara University.
Research Interest
Pharmaceutical